Abstract:Liver transplantation (LT) is an effective and lifesaving treatment for patients with end-stage liver disease and hepatocellular carcinoma. Significant improvement in intermediate and long-term survival has been possible due to advancements in immunosuppressive therapy, perioperative care, and surgical techniques. Despite these advances, metabolic complications, including diabetes mellitus, cardiovascular diseases, malignancies, and renal dysfunction, are challenging issues after LT. Acute kidney injury (AKI) and chronic kidney disease (CKD) after LT are common and result in significant morbidity and mortality. Early diagnosis of kidney injury after LT is challenging, and no technique has yet proven effective in prediction of renal dysfunction. The methods for assessing renal function range from formulas that predict glomerular filtration rate to non-invasive biomarkers. The universal adoption of the model for end-stage liver disease has a direct impact on the incidence of peri-transplant AKI and development of CKD in the long-term. Post-LT renal dysfunction is multifactorial and is usually a result of pre-transplantation comorbidities, occurrence of renal dysfunction on the waiting list, perioperative events, and post-transplant nephrotoxic immunosuppressive medication use. Early identification of patients at risk for renal dysfunction and adoption of preventive measures are crucial in the pre-transplant period. No data are currently available to suggest a surgical technique that reliably demonstrates renal protection. Nephroprotective strategies during LT follow accepted surgical practice guidelines, such as maintenance of intravascular volume and mean arterial pressure. The management of kidney disease following LT is challenging, as by the time the serum creatinine is significantly elevated, few interventions impact the course of progression. Early nephroprotective measures are strongly advised and they mostly center on delaying the administration of calcineurin inhibitors (CNIs) during the initial postoperative period, lowering CNI dosage and combining CNI with mycophenolate mofetil and everolimus. The reasons for renal failure following LT, the techniques used to diagnose it, and the therapies designed to preserve renal function both immediately and late after LT are all critically evaluated in this review.

Perioperative Liver and Kidney Diseases

Preoperative risk evaluation and optimization for patients with liver disease

[Cirrhosis and surgical risk]

Liver protection in the perioperative setting

Perioperative Considerations in Older Kidney and Liver Transplant Recipients: A Review

Update on perioperative management of patients undergoing surgery for liver cancer

Surgical Risk Assessment in Patients with Chronic Liver Diseases

Patient with chronic renal failure undergoing surgery

Update on Perioperative Acute Kidney Injury

Perioperative Assessment and Intraoperative Core Concepts in the Complex Kidney Patient

Management of the risk of bleeding and thrombosis in perioperative patients with liver cirrhosis

Surgery and Chronic Kidney Disease

Perioperative support of hepatic function in patients with liver neoplasms undergoing hepatectomy

Selection and rational use of analgesics in perioperative period of liver transplantation

Perioperative Anesthetic Management of Patients Having Liver Transplantation for Uncommon Conditions

Chronic kidney disease and perioperative outcomes in urological oncological surgery

Optimization of Kidney Health in Liver Transplant Candidates: Pretransplant Considerations and Modalities

Risk Factors for and the Prevention of Acute Kidney Injury after Abdominal Surgery

Perioperative renal protection

Peri-operative safety management in liver transplantation

Post Liver Transplant Renal Dysfunction-Evaluation, Management and Immunosuppressive Practice